When will Lundbeckfond Emerge invest?
A mere two investments are what Lundbeckfond Emerge has made since being founded in the spring of 2012. Will 2014 be the year when new companies are added to the portfolio? The number of new investments should not be an aim in itself, says Partner Christian Elling.
by Benjamin Werner Christensen
Since being established in the spring of 2012, Lundbeckfond Emerge has only invested in the two biotech companies EpiTherapeutics and Insusense Therapeutics. Medwatch spoke to Christian Elling, Partner in Lundbeckfond Emerge, about why the fund has not made more investments and what people can expect in the future.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Something’s stirring…
For abonnenter
